We are live on
!
Find out more
AS
Altshuler Shaham Portfolio holdings
AUM
$8.04B
1-Year Est. Return
44.04%
This Fund
S&P 500
This Quarter
Est. Return
-20.75%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
–
AUM
$6.68B
AUM Growth
-$4.84B
(-42%)
Cap. Flow
-$2.78B
Cap. Flow
% of AUM
-41.52%
Top 10 Holdings %
Top 10 Hldgs %
69.64%
Holding
649
New
126
Increased
62
Reduced
211
Closed
205
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICL Group
ICL
|
+$483M |
| 2 |
Wells Fargo
WFC
|
+$460M |
| 3 |
Bank of America
BAC
|
+$451M |
| 4 |
Citigroup
C
|
+$440M |
| 5 |
JPMorgan Chase
JPM
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.22B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.9B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 4 |
KAHC
KKR Acquisition Holdings I Corp.
KAHC
|
+$47.5M |
| 5 |
Herbalife
HLF
|
+$31.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.37% |
| 2 | Financials | 24.54% |
| 3 | Industrials | 10.55% |
| 4 | Materials | 6.17% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
HEICO Corp
HEI
$51.9B
| $34K | ﹤0.01% |
+258
| New | +$36.4K |
|
302
Viavi Solutions
VIAV
$10.6B
| $34K | ﹤0.01% |
2,585
-521
| -17% | -$7.5K |
|
303
CTS Corp
CTS
$1.79B
| $33K | ﹤0.01% |
+956
| New | +$34.6K |
|
304
CVS Health
CVS
$121B
| $33K | ﹤0.01% |
359
-3,533
| -91% | -$345K |
|
305
HP
HPQ
$28.6B
| $33K | ﹤0.01% |
990
-523
| -35% | -$19.2K |
|
306
Insight Enterprises
NSIT
$4.6B
| $33K | ﹤0.01% |
379
-87
| -19% | -$8.5K |
|
|
SPNS
307
DELISTED
Sapiens International
SPNS
| $33K | ﹤0.01% |
1,350
-20
| -1% | -$483 |
|
308
Corcept Therapeutics
CORT
$11.9B
| $32K | ﹤0.01% |
1,364
-226
| -14% | -$4.92K |
|
309
Harmony Biosciences
HRMY
$2.24B
| $31K | ﹤0.01% |
642
-243
| -27% | -$10.9K |
|
310
Huron Consulting
HURN
$2.47B
| $31K | ﹤0.01% |
+478
| New | +$27K |
|
311
Ionis Pharmaceuticals
IONS
$9.28B
| $31K | ﹤0.01% |
+834
| New | +$31.4K |
|
|
VRNT
312
DELISTED
Verint Systems
VRNT
| $31K | ﹤0.01% |
742
-257
| -26% | -$12.8K |
|
|
AVTA
313
DELISTED
Avantax, Inc. Common Stock
AVTA
| $31K | ﹤0.01% |
1,672
-2,708
| -62% | -$49.2K |
|
314
i3 Verticals
IIIV
$325M
| $30K | ﹤0.01% |
+1,205
| New | +$30.4K |
|
315
Prestige Consumer Healthcare
PBH
$2.43B
| $30K | ﹤0.01% |
515
-139
| -21% | -$7.66K |
|
316
Qiagen
QGEN
$8.93B
| $30K | ﹤0.01% |
589
-235
| -29% | -$11.5K |
|
317
Royalty Pharma
RPRX
$26.1B
| $30K | ﹤0.01% |
+707
| New | +$29K |
|
|
EVOP
318
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $30K | ﹤0.01% |
+1,283
| New | +$29.2K |
|
319
Broadridge
BR
$19.6B
| $29K | ﹤0.01% |
200
-39
| -16% | -$5.66K |
|
320
Cass Information Systems
CASS
$750M
| $29K | ﹤0.01% |
847
-33
| -4% | -$1.19K |
|
321
Chemed
CHE
$7.02B
| $29K | ﹤0.01% |
61
-18
| -23% | -$8.78K |
|
322
Edwards Lifesciences
EW
$53.4B
| $29K | ﹤0.01% |
301
-498
| -62% | -$51.6K |
|
323
Fastenal
FAST
$58.9B
| $29K | ﹤0.01% |
1,178
-216
| -15% | -$5.82K |
|
324
W.W. Grainger
GWW
$62.2B
| $29K | ﹤0.01% |
64
-35
| -35% | -$17K |
|
325
Morningstar
MORN
$7.76B
| $29K | ﹤0.01% |
120
-207
| -63% | -$52.2K |
|
Similar funds
VIM
FIA
EGM
CCM
WA
PC
PGFC
IMCOOI
Altshuler Shaham's Q2 2022 Portfolio in Review
As of Q2 2022, Altshuler Shaham held 649 positions worth $6.68B, down 42% from $11.5B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Altshuler Shaham withdrew a net $2.78B in Q2 2022, closing 205 positions and reducing 211 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $47.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
Against the trend, Altshuler Shaham opened a new position in Elbit Systems worth $259M.
- Altshuler Shaham's largest Q2 2022 buy was Elbit Systems: 1,132,512 shares worth $259M.
- Altshuler Shaham added most to ICL Group in Q2 2022, an estimated $483M increase.
- Altshuler Shaham's biggest Q2 2022 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $2.22B.
- Altshuler Shaham fully exited KKR Acquisition Holdings I Corp. in Q2 2022, selling an estimated $47.5M.
- Altshuler Shaham's ten largest holdings make up 70% of its $6.68B portfolio in Q2 2022.
- Altshuler Shaham opened 126 new positions and closed 205 in Q2 2022.
- Altshuler Shaham's portfolio value fell 42% quarter-over-quarter to $6.68B.
Based on Altshuler Shaham's 13F filing for Q2 2022, filed 10 Aug 2022.